Jingdong Ye

Jingdong Ye is a highly experienced scientist in the field of biotechnology and discovery chemistry, currently serving as a Principal Scientist at Arrowhead Pharmaceuticals since August 2022, focusing on Antibody Oligonucleotide Conjugates for siRNA delivery. Prior to this role, Jingdong held the position of Director of Antibody Discovery Technologies at SPARX THERAPEUTICS, where a range of advanced techniques in antibody humanization and bispecific antibody platform design were developed. Previous positions include serving as a Metrology Specialist and Formulation Chemist at SGS, and an Assistant Professor at the University of Central Florida. Jingdong's academic credentials include a Ph.D. in Chemistry from the University of Chicago and a Bachelor's Degree in Chemical Physics from the University of Science and Technology of China.